Last Updated: May 11, 2026

Patent: 9,452,212

✉ Email this page to a colleague

Summary for Patent: 9,452,212

Title:	Methods and compositions for eliciting an immune response against hepatitis B virus
Abstract:	The present invention relates to immunization of hypo-responsive groups of individuals. In particular, the present invention provides methods and compositions for eliciting a potent immune response to hepatitis B virus in individuals in need thereof.
Inventor(s):	William L. HEYWARD
Assignee:	Dynavax Technologies Corp
Application Number:	US13/448,302
Patent Claims:	see list of patent claims

Details for Patent 9,452,212

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Dynavax Technologies Corporation	HEPLISAV-B	hepatitis b vaccine (recombinant), adjuvanted	Injection	125428	November 09, 2017	⤷ Start Trial	2032-04-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,452,212

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	9884110	⤷ Start Trial
United States of America	2018243407	⤷ Start Trial
United States of America	2017087245	⤷ Start Trial
United States of America	2012263755	⤷ Start Trial
United States of America	10314907	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.